According to the Australian Ocean Health announcement, the cumulative deviation value of the closing price increase of the company's stock exceeded 20% for two consecutive trading days on August 12 and 13, 2026, which is an abnormal situation. After verification, there was no need to correct or supplement the information previously disclosed by the company. No major information was disclosed in media reports, the operating and internal and external environment were normal, the company and controlling shareholders were not required to disclose undisclosed important matters, and the controlling shareholders did not trade the company's shares during this period. The company reminds investors to be aware of the risks.

According to the Australian Ocean Health announcement, the cumulative deviation value of the closing price increase of the company's stock exceeded 20% for two consecutive trading days on August 12 and 13, 2026, which is an abnormal situation. After verification, there was no need to correct or supplement the information previously disclosed by the company. No major information was disclosed in media reports, the operating and internal and external environment were normal, the company and controlling shareholders were not required to disclose undisclosed important matters, and the controlling shareholders did not trade the company's shares during this period. The company reminds investors to be aware of the risks.